Meridian Biosci. (VIVO) Posts Q4 EPS of $0.22, Tops by 1c
More News related to VIVO
- Meridian Bioscience (VIVO) Posts Q1 EPS of $0.22, In-Line with Street; Reaffirms FY10 Guidance
- Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
- Trading Radar for 1/21: Google (GOOG), Goldman Sachs (GS), Western Digital (WDC), Intuitive Surgical (ISRG) Report
- Meridian Biosci. (VIVO) Posts Q4 EPS of $0.22, Tops by 1c
- Trading Radar for 11/12: Wal-Mart (WMT), Blockbuster (BBI), Nordstrom (JWN), Walt Disney (DIS), Kohl's (KSS) Report
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Meridian Bioscience, Inc (NASDAQ: VIVO) reports Q4 EPS of $0.22, 1 cent better than the analyst estimate of $0.21. Revenue for the quarter was $42.5 million, which compares to the estimate of $38.74 million.
Related Categories
EarningsStocks Mentioned
+0.48Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
